EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg

Recent Posts

• FDA Approves First Human Milk-Based Fortifier for Term Infants to Support Growth and Recovery Following Surgery for Gastroschisis
• EW Healthcare Partners Announces Leadership Evolution
• Ascend Advanced Therapies Partners with EW Healthcare Partners to Expand United States Capacity and Capabilities
• BioTissue Earns Top Ranking on Great Place to Work® and 2024 Fortune Best Workplaces in BioPharma™ List
• In Memoriam: Olivier Bohuon